Robert F. Kennedy's Jr. push to remove fluoride from the nation's public water supply could benefit some companies. Here's ...

Other drug manufacturers declined in the days following the nomination. Pfizer and Moderna have declined 6.9% and 6.2% ...

Vaccine and other healthcare stocks retreated sharply on Friday after RFK was selected to lead the US health and human ...

Friday was a doozy for many biotech and pharmaceutical companies after news broke late Thursday that President-elect Donald Trump would nominate vaccine skeptic Robert F. Kennedy Jr. to the nation's ...

Dental care supplier Henry Schein advanced in Monday trading as investors bet that Robert F. Kennedy Jr., President-elect ...

Trump’s selection is sounding the alarm in the public health community and leaving the biotech and pharmaceutical industries ...

Kennedy insists he is not "anti-vaccine," but he has a long record of false and misleading statements​ about their safety and ...

The vaccine skeptic may find it hard to enact earth-shattering changes to American healthcare.

While RFK Jr. has recently attempted to dilute his controversial vaccine beliefs, emphasizing in an interview that "we're not ...

Bavarian Nordic, with a diverse vaccine portfolio and $340 million in contracts for 2025, offers growth potential for ...

Robert F. Kennedy Jr.'s nomination to lead HHS is causing cautious concern among investors. Here's which companies and stocks ...